Abstract: Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the weight and mechanical strength of the polymers from which the lenses are typically formed. Electrospun fibers are also utilized as a drug delivery system, both through direct use in the eye and by inclusion of the fibers in a contact lens. The fibers are loaded with therapeutic drugs by a variety of methods and processed by coating and cross-linking the fibers.
Type:
Grant
Filed:
June 24, 2009
Date of Patent:
January 29, 2013
Assignee:
Ocugenics, LLC
Inventors:
Shachar Tauber, Randall Fuerst, Keela Davis, Lyle Bowman, Gary Wnek, Joseph J. Bango, Jr.
Abstract: Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the weight and mechanical strength of the polymers from which the lenses are typically formed. Electrospun fibers are also utilized as a drug delivery system, both through direct use in the eye and by inclusion of the fibers in a contact lens. The fibers are loaded with therapeutic drugs by a variety of methods and processed by coating and cross-linking the fibers.
Type:
Grant
Filed:
April 1, 2009
Date of Patent:
December 27, 2011
Assignee:
Ocugenics, LLC
Inventors:
Joseph J. Bango, Jr., Lyle Bowman, Gary Wnek, Shachar Tauber, Randall Fuerst
Abstract: A method and means of providing stromal repair and improved refractive correction by creating corneal stromal collagen tissue with fibril diameter and spacing that duplicates the optical transmission and diffusion characteristics of natural corneal collagen. The repair method includes implanting the collagen scaffold during laser corneal ablation or other interlamellar surgery to improve visual acuity or to preclude the possibility of ectasia.
Abstract: A method and means of providing an improved refractive correction contact lens which increases user comfort, retards protein and lipid deposition, and can be utilized for pharmaceutical delivery. The invention discloses a technique for creating polymer fibril diameters and spacing that duplicates the optical transmission and diffusion characteristics of natural corneal collagen.
Type:
Grant
Filed:
December 12, 2003
Date of Patent:
July 21, 2009
Assignee:
Ocugenics, LLC
Inventors:
Randall Fuerst, Joseph Bango, John Fenn, Michael Dziekan